FONTRIDGE PHARMACEUTICAL RESEARCH AND DEVELOPMENT LIMITED
20 HAVELOCK ROAD, HASTINGS  TN34 1BP- Active
- Private Limited Company
- Company No. 04015643
- Last Updated: 02 May 2024
Company Profile
FONTRIDGE PHARMACEUTICAL RESEARCH AND DEVELOPMENT LIMITED was incorporated on Thursday, June 15, 2000 as a Private Limited Company with registered address in HASTINGS. FONTRIDGE PHARMACEUTICAL RESEARCH AND DEVELOPMENT LIMITED has the status: Active and it's listed in the following category: Manufacture of basic pharmaceutical products. This Private Limited Company has been operating for 24 years 8 months and 8 days.
Name | FONTRIDGE PHARMACEUTICAL RESEARCH AND DEVELOPMENT LIMITED |
---|---|
Company number | 04015643 |
Company type | Private Limited Company |
Incorporation date | 15 Jun 2000 |
Status | Active |
Industry (SIC 2007) |
Address
Registered Address |
20 HAVELOCK ROAD HASTINGS TN34 1BP |
---|---|
Country Of Origin |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Mr Hendrik Jurjen Gerardus Kruisinga Nationality: Dutch |
Dates: Wednesday, April 6, 2016 - present
ownership of shares 75 to 100 percent
voting rights 75 to 100 percent
|
Mr Hugo Pieter Johannes Kruisinga Nationality: Dutch |
Dates: Wednesday, April 6, 2016 - present
ownership of shares 75 to 100 percent
voting rights 75 to 100 percent
|
Accounts and Confirmation
Type of accounts | TOTAL EXEMPTION FULL |
---|---|
End of financial Year | 31 December |
Next annual accounts due | 30 September 2024, (-146 days left) |
Latest accounts | 31 December 2022 |
Next confirmation statement due | 29 June 2024 |
Last confirmation statement dated | 15 June 2023 |
Mortgages
No mortgages have been registered against FONTRIDGE PHARMACEUTICAL RESEARCH AND DEVELOPMENT LIMITED.
Previous Names
Name | Change Date |
---|---|
FONTRIDGE PHARMACEUTICAL RESEARCH AND DEVELOPMENT LIMITED | 15 Jun 2000 |